Tripep
Tripep Carries out a Rights Issue
Published in Health Business Week, December 11th, 2009
The Board of Directors of Tripep AB (publ)(STO:TPEP) has on the 27th of November 2009, based on the authorization by the Annual General Meeting resolved to carry out a rights issue. Every existing share entitles to subscribe for one new share during the period 7 - 21 December 2009 at the subscription price SEK 0.50. If the rights issue is subscribed in full it will give the company a capital injection of SEK 17.8 m (before transaction costs which is estimated to SEK 0.7 m).
The Rights Issue aims to give Tripep the financial capacity the company needs for finalizing the ChronVac-C® study and continue the clinical development of a new generation of ChronVac-C®...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2009-12-11)
More Articles from Health Business Week
- 2Insure4Less.com
2Insure4Less.com's New Videos and Slideshows Simplify the Intricacies of Insurance for Potential Shoppers - 5AM Solutions
5AM Solutions Launches Family Helix Community - A.P. Pharma, Inc.
A.P. Pharma Receives Notice of Compliance with Nasdaq Continued Listing Requirements - Aafprs
AAFPRS Opposes the Proposed Tax on Medical Procedures - AARP Idaho
Idaho's Members of Congress Turning Blind Eye to State's Health Care Woes - AARP Illinois
AARP Hosts Rep. Bill Foster In Health Care Reform Forum - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
